Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 231

1.

Lewy Body Dementia Association's Research Centers of Excellence Program: Inaugural Meeting Proceedings.

Peterson B, Armstrong M, Galasko D, Galvin JE, Goldman J, Irwin D, Paulson H, Kaufer D, Leverenz J, Lunde A, McKeith IG, Siderowf A, Taylor A, Amodeo K, Barrett M, Domoto-Reilly K, Duda J, Gomperts S, Graff-Radford N, Holden S, Honig L, Huddleston D, Lippa C, Litvan I, Manning C, Marder K, Moussa C, Onyike C, Pagan F, Pantelyat A, Pelak V, Poston K, Quinn J, Richard I, Rosenthal LS, Sabbagh M, Scharre D, Sha S, Shill H, Torres-Yaghi Y, Christie T, Graham T, Richards I, Koehler M, Boeve B.

Alzheimers Res Ther. 2019 Mar 13;11(1):23. doi: 10.1186/s13195-019-0476-1.

2.

Consecutive sessions of transcranial direct current stimulation do not remediate visual hallucinations in Lewy body dementia: a randomised controlled trial.

Elder GJ, Colloby SJ, Firbank MJ, McKeith IG, Taylor JP.

Alzheimers Res Ther. 2019 Jan 18;11(1):9. doi: 10.1186/s13195-018-0465-9.

3.

Extravascular fibrinogen in the white matter of Alzheimer's disease and normal aged brains: implications for fibrinogen as a biomarker for Alzheimer's disease.

McAleese KE, Graham S, Dey M, Walker L, Erskine D, Johnson M, Johnston E, Thomas AJ, McKeith IG, DeCarli C, Attems J.

Brain Pathol. 2019 May;29(3):414-424. doi: 10.1111/bpa.12685. Epub 2019 Jan 29.

PMID:
30485582
4.

The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target.

Petyuk VA, Chang R, Ramirez-Restrepo M, Beckmann ND, Henrion MYR, Piehowski PD, Zhu K, Wang S, Clarke J, Huentelman MJ, Xie F, Andreev V, Engel A, Guettoche T, Navarro L, De Jager P, Schneider JA, Morris CM, McKeith IG, Perry RH, Lovestone S, Woltjer RL, Beach TG, Sue LI, Serrano GE, Lieberman AP, Albin RL, Ferrer I, Mash DC, Hulette CM, Ervin JF, Reiman EM, Hardy JA, Bennett DA, Schadt E, Smith RD, Myers AJ.

Brain. 2018 Sep 1;141(9):2721-2739. doi: 10.1093/brain/awy215.

5.

Molecular changes in the absence of severe pathology in the pulvinar in dementia with Lewy bodies.

Erskine D, Ding J, Thomas AJ, Kaganovich A, Khundakar AA, Hanson PS, Taylor JP, McKeith IG, Attems J, Cookson MR, Morris CM.

Mov Disord. 2018 Jul;33(6):982-991. doi: 10.1002/mds.27333. Epub 2018 Mar 23.

6.

Clinical prevalence of Lewy body dementia.

Kane JPM, Surendranathan A, Bentley A, Barker SAH, Taylor JP, Thomas AJ, Allan LM, McNally RJ, James PW, McKeith IG, Burn DJ, O'Brien JT.

Alzheimers Res Ther. 2018 Feb 15;10(1):19. doi: 10.1186/s13195-018-0350-6.

7.

Author response: Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.

McKeith IG.

Neurology. 2018 Feb 6;90(6):300-301. doi: 10.1212/WNL.0000000000004919. No abstract available.

PMID:
29438029
8.

Neuropsychiatric symptoms and cognitive profile in mild cognitive impairment with Lewy bodies.

Donaghy PC, Taylor JP, O'Brien JT, Barnett N, Olsen K, Colloby SJ, Lloyd J, Petrides G, McKeith IG, Thomas AJ.

Psychol Med. 2018 Oct;48(14):2384-2390. doi: 10.1017/S0033291717003956. Epub 2018 Jan 24.

PMID:
29362011
9.

Regional levels of physiological α-synuclein are directly associated with Lewy body pathology.

Erskine D, Patterson L, Alexandris A, Hanson PS, McKeith IG, Attems J, Morris CM.

Acta Neuropathol. 2018 Jan;135(1):153-154. doi: 10.1007/s00401-017-1787-6. Epub 2017 Nov 13. No abstract available.

PMID:
29134319
10.

Transcranial direct current stimulation in Parkinson's disease dementia: A randomised double-blind crossover trial.

Elder GJ, Ashcroft J, da Silva Morgan K, Umme Kulsum M, Banerjee R, Chatterjee P, Firbank MJ, McKeith IG, Kumar H, Taylor JP.

Brain Stimul. 2017 Nov - Dec;10(6):1150-1151. doi: 10.1016/j.brs.2017.07.012. Epub 2017 Jul 31. No abstract available.

PMID:
28802804
11.

Parietal white matter lesions in Alzheimer's disease are associated with cortical neurodegenerative pathology, but not with small vessel disease.

McAleese KE, Walker L, Graham S, Moya ELJ, Johnson M, Erskine D, Colloby SJ, Dey M, Martin-Ruiz C, Taylor JP, Thomas AJ, McKeith IG, De Carli C, Attems J.

Acta Neuropathol. 2017 Sep;134(3):459-473. doi: 10.1007/s00401-017-1738-2. Epub 2017 Jun 21.

12.

Diagnosis and management of dementia with Lewy bodies: Fourth consensus report of the DLB Consortium.

McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D, Aarsland D, Galvin J, Attems J, Ballard CG, Bayston A, Beach TG, Blanc F, Bohnen N, Bonanni L, Bras J, Brundin P, Burn D, Chen-Plotkin A, Duda JE, El-Agnaf O, Feldman H, Ferman TJ, Ffytche D, Fujishiro H, Galasko D, Goldman JG, Gomperts SN, Graff-Radford NR, Honig LS, Iranzo A, Kantarci K, Kaufer D, Kukull W, Lee VMY, Leverenz JB, Lewis S, Lippa C, Lunde A, Masellis M, Masliah E, McLean P, Mollenhauer B, Montine TJ, Moreno E, Mori E, Murray M, O'Brien JT, Orimo S, Postuma RB, Ramaswamy S, Ross OA, Salmon DP, Singleton A, Taylor A, Thomas A, Tiraboschi P, Toledo JB, Trojanowski JQ, Tsuang D, Walker Z, Yamada M, Kosaka K.

Neurology. 2017 Jul 4;89(1):88-100. doi: 10.1212/WNL.0000000000004058. Epub 2017 Jun 7. Review.

13.

Symptoms associated with Lewy body disease in mild cognitive impairment.

Donaghy PC, Barnett N, Olsen K, Taylor JP, McKeith IG, O'Brien JT, Thomas AJ.

Int J Geriatr Psychiatry. 2017 Nov;32(11):1163-1171. doi: 10.1002/gps.4742. Epub 2017 May 29.

PMID:
28556415
14.

Quantitative neuropathology: an update on automated methodologies and implications for large scale cohorts.

Walker L, McAleese KE, Johnson M, Khundakar AA, Erskine D, Thomas AJ, McKeith IG, Attems J.

J Neural Transm (Vienna). 2017 Jun;124(6):671-683. doi: 10.1007/s00702-017-1702-2. Epub 2017 Mar 6.

15.

Neuronal Loss and Α-Synuclein Pathology in the Superior Colliculus and Its Relationship to Visual Hallucinations in Dementia with Lewy Bodies.

Erskine D, Thomas AJ, Taylor JP, Savage MA, Attems J, McKeith IG, Morris CM, Khundakar AA.

Am J Geriatr Psychiatry. 2017 Jun;25(6):595-604. doi: 10.1016/j.jagp.2017.01.005. Epub 2017 Jan 10.

PMID:
28190674
16.

Specific patterns of neuronal loss in the pulvinar nucleus in dementia with lewy bodies.

Erskine D, Thomas AJ, Attems J, Taylor JP, McKeith IG, Morris CM, Khundakar AA.

Mov Disord. 2017 Mar;32(3):414-422. doi: 10.1002/mds.26887. Epub 2017 Jan 6.

PMID:
28059471
17.

TDP-43 pathology in Alzheimer's disease, dementia with Lewy bodies and ageing.

McAleese KE, Walker L, Erskine D, Thomas AJ, McKeith IG, Attems J.

Brain Pathol. 2017 Jul;27(4):472-479. doi: 10.1111/bpa.12424. Epub 2016 Aug 24.

PMID:
27495267
18.

Arguing against the proposed definition changes of PD.

Boeve BF, Dickson DW, Duda JE, Ferman TJ, Galasko DR, Galvin JE, Goldman JG, Growdon JH, Hurtig HI, Kaufer DI, Kantarci K, Leverenz JB, Lippa CF, Lopez OL, McKeith IG, Singleton AB, Taylor A, Tsuang D, Weintraub D, Zabetian CP.

Mov Disord. 2016 Nov;31(11):1619-1622. doi: 10.1002/mds.26721. Epub 2016 Aug 5.

19.

Analysis of primary visual cortex in dementia with Lewy bodies indicates GABAergic involvement associated with recurrent complex visual hallucinations.

Khundakar AA, Hanson PS, Erskine D, Lax NZ, Roscamp J, Karyka E, Tsefou E, Singh P, Cockell SJ, Gribben A, Ramsay L, Blain PG, Mosimann UP, Lett DJ, Elstner M, Turnbull DM, Xiang CC, Brownstein MJ, O'Brien JT, Taylor JP, Attems J, Thomas AJ, McKeith IG, Morris CM.

Acta Neuropathol Commun. 2016 Jun 30;4(1):66. doi: 10.1186/s40478-016-0334-3.

20.

Cholinergic and perfusion brain networks in Parkinson disease dementia.

Colloby SJ, McKeith IG, Burn DJ, Wyper DJ, O'Brien JT, Taylor JP.

Neurology. 2016 Jul 12;87(2):178-85. doi: 10.1212/WNL.0000000000002839. Epub 2016 Jun 15.

21.

Exome sequencing in dementia with Lewy bodies.

Keogh MJ, Kurzawa-Akanbi M, Griffin H, Douroudis K, Ayers KL, Hussein RI, Hudson G, Pyle A, Cordell HJ, Attems J, McKeith IG, O'Brien JT, Burn DJ, Morris CM, Thomas AJ, Chinnery PF.

Transl Psychiatry. 2016 Feb 2;6:e728. doi: 10.1038/tp.2015.220.

22.

Depressive symptoms are associated with daytime sleepiness and subjective sleep quality in dementia with Lewy bodies.

Elder GJ, Colloby SJ, Lett DJ, O'Brien JT, Anderson KN, Burn DJ, McKeith IG, Taylor JP.

Int J Geriatr Psychiatry. 2016 Jul;31(7):765-70. doi: 10.1002/gps.4389. Epub 2015 Nov 11.

23.

Resting state in Parkinson's disease dementia and dementia with Lewy bodies: commonalities and differences.

Peraza LR, Colloby SJ, Firbank MJ, Greasy GS, McKeith IG, Kaiser M, O'Brien J, Taylor JP.

Int J Geriatr Psychiatry. 2015 Nov;30(11):1135-46. doi: 10.1002/gps.4342. Epub 2015 Aug 13.

24.

Regional covariance of muscarinic acetylcholine receptors in Alzheimer's disease using (R, R) [(123)I]-QNB SPECT.

Colloby SJ, McKeith IG, Wyper DJ, O'Brien JT, Taylor JP.

J Neurol. 2015 Sep;262(9):2144-53. doi: 10.1007/s00415-015-7827-z. Epub 2015 Jun 30.

PMID:
26122542
25.

Changes to the lateral geniculate nucleus in Alzheimer's disease but not dementia with Lewy bodies.

Erskine D, Taylor JP, Firbank MJ, Patterson L, Onofrj M, O'Brien JT, McKeith IG, Attems J, Thomas AJ, Morris CM, Khundakar AA.

Neuropathol Appl Neurobiol. 2016 Jun;42(4):366-76. doi: 10.1111/nan.12249. Epub 2015 Jun 2.

26.

Clinicians' ability to diagnose dementia with Lewy bodies is not affected by β-amyloid load.

Tiraboschi P, Attems J, Thomas A, Brown A, Jaros E, Lett DJ, Ossola M, Perry RH, Ramsay L, Walker L, McKeith IG.

Neurology. 2015 Feb 3;84(5):496-9. doi: 10.1212/WNL.0000000000001204. Epub 2014 Dec 31.

27.

The clinical characteristics of dementia with Lewy bodies and a consideration of prodromal diagnosis.

Donaghy PC, McKeith IG.

Alzheimers Res Ther. 2014 Jul 21;6(4):46. doi: 10.1186/alzrt274. eCollection 2014. Review.

28.

Accumulation of dipeptide repeat proteins predates that of TDP-43 in frontotemporal lobar degeneration associated with hexanucleotide repeat expansions in C9ORF72 gene.

Baborie A, Griffiths TD, Jaros E, Perry R, McKeith IG, Burn DJ, Masuda-Suzukake M, Hasegawa M, Rollinson S, Pickering-Brown S, Robinson AC, Davidson YS, Mann DM.

Neuropathol Appl Neurobiol. 2015 Aug;41(5):601-12. doi: 10.1111/nan.12178. Epub 2015 Apr 30.

29.

Is ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials.

O'Brien JT, Oertel WH, McKeith IG, Grosset DG, Walker Z, Tatsch K, Tolosa E, Sherwin PF, Grachev ID.

BMJ Open. 2014 Jul 3;4(7):e005122. doi: 10.1136/bmjopen-2014-005122.

30.

Frontotemporal dementia and its subtypes: a genome-wide association study.

Ferrari R, Hernandez DG, Nalls MA, Rohrer JD, Ramasamy A, Kwok JB, Dobson-Stone C, Brooks WS, Schofield PR, Halliday GM, Hodges JR, Piguet O, Bartley L, Thompson E, Haan E, Hernández I, Ruiz A, Boada M, Borroni B, Padovani A, Cruchaga C, Cairns NJ, Benussi L, Binetti G, Ghidoni R, Forloni G, Galimberti D, Fenoglio C, Serpente M, Scarpini E, Clarimón J, Lleó A, Blesa R, Waldö ML, Nilsson K, Nilsson C, Mackenzie IR, Hsiung GY, Mann DM, Grafman J, Morris CM, Attems J, Griffiths TD, McKeith IG, Thomas AJ, Pietrini P, Huey ED, Wassermann EM, Baborie A, Jaros E, Tierney MC, Pastor P, Razquin C, Ortega-Cubero S, Alonso E, Perneczky R, Diehl-Schmid J, Alexopoulos P, Kurz A, Rainero I, Rubino E, Pinessi L, Rogaeva E, St George-Hyslop P, Rossi G, Tagliavini F, Giaccone G, Rowe JB, Schlachetzki JC, Uphill J, Collinge J, Mead S, Danek A, Van Deerlin VM, Grossman M, Trojanowski JQ, van der Zee J, Deschamps W, Van Langenhove T, Cruts M, Van Broeckhoven C, Cappa SF, Le Ber I, Hannequin D, Golfier V, Vercelletto M, Brice A, Nacmias B, Sorbi S, Bagnoli S, Piaceri I, Nielsen JE, Hjermind LE, Riemenschneider M, Mayhaus M, Ibach B, Gasparoni G, Pichler S, Gu W, Rossor MN, Fox NC, Warren JD, Spillantini MG, Morris HR, Rizzu P, Heutink P, Snowden JS, Rollinson S, Richardson A, Gerhard A, Bruni AC, Maletta R, Frangipane F, Cupidi C, Bernardi L, Anfossi M, Gallo M, Conidi ME, Smirne N, Rademakers R, Baker M, Dickson DW, Graff-Radford NR, Petersen RC, Knopman D, Josephs KA, Boeve BF, Parisi JE, Seeley WW, Miller BL, Karydas AM, Rosen H, van Swieten JC, Dopper EG, Seelaar H, Pijnenburg YA, Scheltens P, Logroscino G, Capozzo R, Novelli V, Puca AA, Franceschi M, Postiglione A, Milan G, Sorrentino P, Kristiansen M, Chiang HH, Graff C, Pasquier F, Rollin A, Deramecourt V, Lebert F, Kapogiannis D, Ferrucci L, Pickering-Brown S, Singleton AB, Hardy J, Momeni P.

Lancet Neurol. 2014 Jul;13(7):686-99. doi: 10.1016/S1474-4422(14)70065-1.

31.

Covariant perfusion patterns provide clues to the origin of cognitive fluctuations and attentional dysfunction in dementia with Lewy bodies.

Taylor JP, Colloby SJ, McKeith IG, O'Brien JT.

Int Psychogeriatr. 2013 Dec;25(12):1917-28. doi: 10.1017/S1041610213001488. Epub 2013 Oct 23.

32.

Decreased immunoreactivities of neocortical AMPA receptor subunits correlate with motor disability in Lewy body dementias.

Mohamed NE, Howlett DR, Ma L, Francis PT, Aarsland D, Ballard CG, McKeith IG, Chen CP, Lai MK.

J Neural Transm (Vienna). 2014 Jan;121(1):71-8. doi: 10.1007/s00702-013-1067-0. Epub 2013 Jul 12.

PMID:
23846847
33.

Distinct cognitive phenotypes in Alzheimer's disease in older people.

Vardy ER, Ford AH, Gallagher P, Watson R, McKeith IG, Blamire A, O'Brien JT.

Int Psychogeriatr. 2013 Oct;25(10):1659-66. doi: 10.1017/S1041610213000914. Epub 2013 Jul 5.

PMID:
23830521
34.

A multicenter study of glucocerebrosidase mutations in dementia with Lewy bodies.

Nalls MA, Duran R, Lopez G, Kurzawa-Akanbi M, McKeith IG, Chinnery PF, Morris CM, Theuns J, Crosiers D, Cras P, Engelborghs S, De Deyn PP, Van Broeckhoven C, Mann DM, Snowden J, Pickering-Brown S, Halliwell N, Davidson Y, Gibbons L, Harris J, Sheerin UM, Bras J, Hardy J, Clark L, Marder K, Honig LS, Berg D, Maetzler W, Brockmann K, Gasser T, Novellino F, Quattrone A, Annesi G, De Marco EV, Rogaeva E, Masellis M, Black SE, Bilbao JM, Foroud T, Ghetti B, Nichols WC, Pankratz N, Halliday G, Lesage S, Klebe S, Durr A, Duyckaerts C, Brice A, Giasson BI, Trojanowski JQ, Hurtig HI, Tayebi N, Landazabal C, Knight MA, Keller M, Singleton AB, Wolfsberg TG, Sidransky E.

JAMA Neurol. 2013 Jun;70(6):727-35. doi: 10.1001/jamaneurol.2013.1925.

35.

Elderly individuals with FTLD.

Baborie A, Griffiths TD, Jaros E, Momeni P, McKeith IG, Burn DJ, Keir G, Larner AJ, Mann DM, Perry R.

JAMA Neurol. 2013 Mar 1;70(3):412-3. doi: 10.1001/jamaneurol.2013.1649. No abstract available.

PMID:
23478838
36.

Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: a systematic review.

Christa Maree Stephan B, Minett T, Pagett E, Siervo M, Brayne C, McKeith IG.

BMJ Open. 2013 Feb 4;3(2). pii: e001909. doi: 10.1136/bmjopen-2012-001909. Print 2013.

37.

Multivariate spatial covariance analysis of 99mTc-exametazime SPECT images in dementia with Lewy bodies and Alzheimer's disease: utility in differential diagnosis.

Colloby SJ, Taylor JP, Davison CM, Lloyd JJ, Firbank MJ, McKeith IG, O'Brien JT.

J Cereb Blood Flow Metab. 2013 Apr;33(4):612-8. doi: 10.1038/jcbfm.2013.2. Epub 2013 Jan 30.

38.

Cognitive decline and dementia risk in older adults with psychotic symptoms: a prospective cohort study.

Köhler S, Allardyce J, Verhey FR, McKeith IG, Matthews F, Brayne C, Savva GM; Medical Research Council Cognitive Function and Ageing Study.

Am J Geriatr Psychiatry. 2013 Feb;21(2):119-28. doi: 10.1016/j.jagp.2012.10.010. Epub 2013 Jan 22.

PMID:
23343485
39.

Synaptic proteins and choline acetyltransferase loss in visual cortex in dementia with Lewy bodies.

Mukaetova-Ladinska EB, Andras A, Milne J, Abdel-All Z, Borr I, Jaros E, Perry RH, Honer WG, Cleghorn A, Doherty J, McIntosh G, Perry EK, Kalaria RN, McKeith IG.

J Neuropathol Exp Neurol. 2013 Jan;72(1):53-60. doi: 10.1097/NEN.0b013e31827c5710.

PMID:
23242284
40.

The assessment of cognition in visually impaired older adults.

Killen A, Firbank MJ, Collerton D, Clarke M, Jefferis JM, Taylor JP, McKeith IG, Mosimann UP.

Age Ageing. 2013 Jan;42(1):98-102. doi: 10.1093/ageing/afs157. Epub 2012 Oct 28.

41.

Glucocerebrosidase mutations alter the endoplasmic reticulum and lysosomes in Lewy body disease.

Kurzawa-Akanbi M, Hanson PS, Blain PG, Lett DJ, McKeith IG, Chinnery PF, Morris CM.

J Neurochem. 2012 Oct;123(2):298-309. doi: 10.1111/j.1471-4159.2012.07879.x. Epub 2012 Aug 22.

42.

Supporting clinical research in the NHS in England: the National Institute for Health Research Dementias and Neurodegenerative Diseases Research Network.

Kotting P, Beicher K, McKeith IG, Rossor MN.

Alzheimers Res Ther. 2012 Jul 6;4(4):23. doi: 10.1186/alzrt126. eCollection 2012. Review.

43.

Frontotemporal dementia in elderly individuals.

Baborie A, Griffiths TD, Jaros E, Momeni P, McKeith IG, Burn DJ, Keir G, Larner AJ, Mann DM, Perry R.

Arch Neurol. 2012 Aug;69(8):1052-60. Review.

PMID:
22529248
44.

Visual cortex in dementia with Lewy bodies: magnetic resonance imaging study.

Taylor JP, Firbank MJ, He J, Barnett N, Pearce S, Livingstone A, Vuong Q, McKeith IG, O'Brien JT.

Br J Psychiatry. 2012 Jun;200(6):491-8. doi: 10.1192/bjp.bp.111.099432. Epub 2012 Apr 12.

45.

Relationship between mitochondria and α-synuclein: a study of single substantia nigra neurons.

Reeve AK, Park TK, Jaros E, Campbell GR, Lax NZ, Hepplewhite PD, Krishnan KJ, Elson JL, Morris CM, McKeith IG, Turnbull DM.

Arch Neurol. 2012 Mar;69(3):385-93. doi: 10.1001/archneurol.2011.2675.

PMID:
22410447
46.

Alzheimer and vascular neuropathological changes associated with different cognitive States in a non-demented sample.

Stephan BC, Matthews FE, Ma B, Muniz G, Hunter S, Davis D, McKeith IG, Foster G, Ince PG, Brayne C.

J Alzheimers Dis. 2012;29(2):309-18. doi: 10.3233/JAD-2011-110518.

47.

Impact of less common and "disregarded" neurodegenerative pathologies on dementia burden in a population-based cohort.

Keage HA, Ince PG, Matthews FE, Wharton SB, McKeith IG, Brayne C; MRC CFAS and CC75C.

J Alzheimers Dis. 2012;28(2):485-93. doi: 10.3233/JAD-2011-111268.

PMID:
22045491
48.

Visual hallucinations in dementia with Lewy bodies: transcranial magnetic stimulation study.

Taylor JP, Firbank M, Barnett N, Pearce S, Livingstone A, Mosimann U, Eyre J, McKeith IG, O'Brien JT.

Br J Psychiatry. 2011 Dec;199(6):492-500. doi: 10.1192/bjp.bp.110.090373. Epub 2011 Oct 20.

49.

Neuropathological profile of mild cognitive impairment from a population perspective.

Stephan BC, Matthews FE, Hunter S, Savva GM, Bond J, McKeith IG, Ince P, Brayne C; Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

Alzheimer Dis Assoc Disord. 2012 Jul-Sep;26(3):205-12.

PMID:
21946014
50.

Plasma homocysteine and cognitive decline in older hypertensive subjects.

Narayan SK, Saxby BK, Firbank MJ, O'Brien JT, Harrington F, McKeith IG, Hansrani M, Stansby G, Ford GA.

Int Psychogeriatr. 2011 Dec;23(10):1607-15. doi: 10.1017/S1041610211000779. Epub 2011 May 6.

PMID:
21554791

Supplemental Content

Loading ...
Support Center